Capesaris: Phase II started

In September, GTx said it began the open-label, U.S. Phase II G200712 trial to evaluate 125,

Read the full 169 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE